Nicki Vasquez - 12 Jul 2022 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
Chief Port. Strat & Alnce Ofcr
Signature
/s/ Edward C. Albini as attorney-in-fact for Nicki Vasquez
Issuer symbol
STRO
Transactions as of
12 Jul 2022
Net transactions value
-$6,828
Form type
4
Filing time
13 Jul 2022, 18:24:34 UTC
Previous filing
07 Mar 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRO Common Stock Options Exercise $0 +3,250 +27% $0.000000 15,243 12 Jul 2022 Direct
transaction STRO Common Stock Tax liability $6,828 -1,123 -7.4% $6.08 14,120 12 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Restricted Stock Unit (RSU) Options Exercise $0 -3,250 -25% $0.000000 9,750 12 Jul 2022 Common Stock 3,250 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
F2 Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3 The RSUs vest as to 1/4th of the total shares annually beginning on July 12, 2022, subject to continued service through each vesting date.